Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000).
Authors: Dyson S J
Journal: Equine veterinary journal
Summary
# Editorial Summary Dyson's longitudinal analysis of 219 horses with superficial digital flexor tendonitis reveals that intralesional hyaluronan and systemic or intralesional polysulphated glycosaminoglycans offer no advantage over controlled exercise alone, with all three approaches yielding similar reinjury rates of 42.5–44.4% within 2 years of returning to work. Intralesional injection of beta aminoproprionitrile fumarate (BAPN) demonstrated significantly superior outcomes, reducing reinjury in the treated limb to just 16%, though this protective effect did not extend to preventing new injuries in the contralateral limb. Fibre alignment score at 4 months post-treatment emerged as a reliable prognostic indicator for the treated limb, enabling clinicians to counsel owners on expected outcomes with greater precision. Reinjury risk varied substantially across disciplines, increasing from showjumpers through event horses to National Hunt and flat racehorses, suggesting that return-to-work protocols may need discipline-specific tailoring. For equine practitioners, these findings underscore that whilst BAPN merits consideration for horses requiring athletic return, rigorous exercise management forms the cornerstone of SDF tendonitis rehabilitation, and ultrasonographic assessment at 4 months provides valuable prognostic information for both client communication and post-rehabilitation management decisions.
Read the full abstract on PubMed
Practical Takeaways
- •BAPN intralesional injection combined with modified exercise significantly improves outcome for SDF tendonitis compared to other medical treatments, reducing reinjury risk from ~43% to 16% in treated limbs
- •Standard medical treatments (hyaluronan, PSGAG) offer no advantage over controlled exercise alone for managing SDF tendonitis—exercise programme is the foundation of care
- •Assess fibre alignment via ultrasound at 4 months to predict likelihood of successful return to work; this imaging finding guides realistic prognosis for owners
Key Findings
- •Intralesional hyaluronan, intralesional and systemic PSGAG, and systemic PSGAG alone showed no significant difference in reinjury rates (42.5-44.4%) compared to controlled exercise alone
- •Intralesional BAPN treatment significantly reduced reinjury rate in treated limbs to 16% versus 42.5-44.4% in other groups (P<0.001)
- •Fibre alignment score at 4 months post-treatment was a strong predictor of outcome in treated limbs (P<0.001)
- •Risk of reinjury varied by discipline, with flat racehorses and National Hunt horses at highest risk, followed by event horses, then showjumpers